# Welcome

[[Publications List]](publications.md)  [[CABS Ranked]](ref.md)  [[Clinical Trials]](clinical_trials.md)

---
## About
I am an AI architect and Academic affiliated with the Information Systems and Databases Lab, at the Department of Informatics of Ionian University, Corfu, Greece. I colaborate as an external raporteur with [OECD](oecd.ai). Ι work in various various areas of analytics and collaborate with [Adastra](http://www.adastragrp.com) as a data scientist in residence, working on R&D activities in analytics, data engineering and applications of AI in business contexts including generative and inferential. I am also a professional clinical research statistician and I am affiliated with HECOG (Hellenic Cooperative Oncology Group) as a Senior Statistician.   
You can see a partial list of my publications in my [Google Scholar Profile](https://scholar.google.com/citations?user=T4VGRUIAAAAJ&hl=en).

If you are interested in any of the following, please don't hesitate to contact me:

* Research collaboration
* Data science and analytics training, including upskilling and reskilling
* Consulting

---
## Clinical Trials

ClinicalTrials.gov Identifier: **[NCT03568097](https://clinicaltrials.gov/study/NCT03568097)** - PAVE: Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung Cancer
   * Mountzios, G., Papadopoulou, K., Korfiatis, N., Goussia, A., Samantas, E., et al. (2025). Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis. *European Journal of Cancer*, 228, 115660.

ClinicalTrials.gov Identifier: **[NCT05372081](https://clinicaltrials.gov/study/NCT05372081)** - SNF-CLIMEDIN: Digital support and intervention in patients with advanced NSCLC
   * Kosmidis, P.A., Kosmidis, T., Papadopoulou, K., Korfiatis, N., Vozikis, A., et al. (2025). SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLC—Final results. *Journal of Clinical Oncology*, 43(16_suppl), 1515-1515.

ClinicalTrials.gov Identifier: **[NCT03311750](https://clinicaltrials.gov/study/NCT03311750)** - A-REPEAT: Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer
   * Sgouros, J., Eliades, A., Papadopoulou, K., Korfiatis, N., Papamichael, D., et al. (2025). Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping. *ESMO Gastrointestinal Oncology*, 7, 100120.

[See Full List](clinical_trials.md)

---
## Recent and Forthcoming Publications

* Dousios, D., Korfiatis, N., & Spanaki, K. (2025). The Persuasive Impact of Text and Audio Features on Technology Crowdfunding Campaigns. _IEEE Transactions on Engineering Management_, 72, 2049-2064.

* Kleitsikas, C., Korfiatis, N., Leonardos, S., & Ventre, C. (2025). Bitcoin's Edge: Embedded Sentiment in Blockchain Transactional Data. _IEEE International Conference on Blockchain and Cryptocurrency 2025_.

* Kosmidis, P.A., Kosmidis, T., Papadopoulou, K., Korfiatis, N., Vozikis, A., et al. (2025). SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLC. _Journal of Clinical Oncology_, 43(16_suppl), 1515-1515.

[See Full List](publications.md)
